Uprety D, Abrahami D, Marcum ZA, Li B, et al. Brain metastases and mortality in patients with ALK + metastatic non-small cell lung cancer treated with second-generation ALK tyrosine kinase inhibitors as first-line targeted therapies: An observational cohort study. Lung Cancer 2025;201:108436.
PMID: 39947094